In Figure 5A, a comparison between the treatment groups reveals significant alterations in brain AChE levels (ng/g protein) following T2DM induction and subsequent SITG treatment (F(4,25) = 21.38, p < 0.001). The gene discussed is ACHE; the disease is type 2 diabetes mellitus.